Childhood Medulloepithelioma [clinicaltrials_resource:0e60417dd5cdfa7ba6822d82527e5239]
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors [clinicaltrials:NCT00052780]Cilengitide in Treating Children With Refractory Primary Brain Tumors [clinicaltrials:NCT00063973]Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors [clinicaltrials:NCT00100880]ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors [clinicaltrials:NCT00946335]Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma [clinicaltrials:NCT00994500]Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors [clinicaltrials:NCT01076530]Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia [clinicaltrials:NCT01088763]Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors [clinicaltrials:NCT02194452]Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors [clinicaltrials:NCT02255461]
condition [clinicaltrials_vocabulary:condition]
Childhood Medulloepithelioma [clinicaltrials_resource:0e60417dd5cdfa7ba6822d82527e5239]
Bio2RDF identifier
0e60417dd5cdfa7ba6822d82527e5239
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0e60417dd5cdfa7ba6822d82527e5239
identifier
clinicaltrials_resource:0e60417dd5cdfa7ba6822d82527e5239
title
Childhood Medulloepithelioma
@en
label
Childhood Medulloepithelioma [clinicaltrials_resource:0e60417dd5cdfa7ba6822d82527e5239]
@en